Found: 7
Select item for more details and to access through your institution.
BCR signals target p27<sup>Kip1</sup> and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
- Published in:
- Oncogene, 2001, v. 20, n. 50, p. 7352, doi. 10.1038/sj.onc.1204951
- By:
- Publication type:
- Article
BCR targets cyclin D2 via Btk and the p85a subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
- Published in:
- Oncogene, 2003, v. 22, n. 15, p. 2248, doi. 10.1038/sj.onc.1206425
- By:
- Publication type:
- Article
CD20-positive multiple myeloma – differential expression of cyclins D1 and D2 suggests a heterogeneous disease.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 2, p. 243, doi. 10.1111/j.1365-2141.2007.06789.x
- By:
- Publication type:
- Article
Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development.
- Published in:
- International Immunology, 2000, v. 12, n. 5, p. 631, doi. 10.1093/intimm/12.5.631
- By:
- Publication type:
- Article
Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes.
- Published in:
- European Journal of Immunology, 2005, v. 35, n. 9, p. 2748, doi. 10.1002/eji.200425812
- By:
- Publication type:
- Article
Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors.
- Published in:
- European Journal of Immunology, 1999, v. 29, n. 10, p. 3380, doi. 10.1002/(SICI)1521-4141(199910)29:10<3380::AID-IMMU3380>3.0.CO;2-C
- By:
- Publication type:
- Article